Join
Live feed
·
INSIDERFilingvia Quantisnow
TG Therapeutics Inc. logo

SEC Form 4: Weiss Michael S bought $1,013,000 worth of shares (100,000 units at $10.13), increasing direct ownership by 0.84% to 12,073,021 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TGTX (TG Therapeutics Inc.) and more on Quantisnow.